09688

再鼎醫藥

16.250

-0.170-1.04%
Closed16:09 04/10 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE18.160/18.160
TODAY RANGE17.990-18.560
VOL6.26M
MARKET CAP20.68B
52 WEEK RANGE12.310-35.500
AVG VOL (3M)10.17M
% TURNOVER0.55%
TURNOVER114.41M
P/E (TTM)-15.135
% RANGE3.14%
EPS(TTM)-1.205
P/E(FORWARD)-12.828
P/B3.713
BVPS4.910
DIVIDEND--
P/S5.774
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP20.68B
SHARES OUTSTANDING1.13B
NEXT EARNINGS05/06-05/11
FREE FLOAT1.13B
LOT SIZE100
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

再鼎醫藥

09688

-1.04%
16.250

A

Amgen

04332

0.00%

藥明康德

02359

+0.62%
129.700

海螺創業

00586

+0.89%
12.460

凱萊英

06821

-1.76%
95.100

國藥控股

01099

-0.76%
20.920

白雲山

00874

+0.24%
16.980

L

Livzon Pharmaceutical Group

01513

-1.36%
29.000

上海醫藥

02607

+0.25%
11.990

復星醫藥

02196

-0.30%
19.960

康哲藥業

00867

-0.63%
14.300

06600

--

藥明生物

02269

+1.01%
35.900

中國同輻

01763

0.00%
19.980

神威藥業

02877

+1.43%
9.940

聯邦制藥

03933

-0.69%
10.090

C

Consun Pharmaceutical Group

01681

0.00%
17.020

三生製藥

01530

+0.70%
22.960

山東新華製藥股份

00719

+0.47%
6.390

同仁堂國藥

03613

+0.13%
7.730

華潤醫藥

03320

+0.63%
6.340

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.